VisionPoint Advisory Group LLC Has $172,000 Position in Danaher Co. (NYSE:DHR)

VisionPoint Advisory Group LLC lowered its stake in shares of Danaher Co. (NYSE:DHR) by 16.1% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 745 shares of the conglomerate’s stock after selling 143 shares during the period. VisionPoint Advisory Group LLC’s holdings in Danaher were worth $172,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. BKM Wealth Management LLC acquired a new stake in shares of Danaher in the 4th quarter valued at $27,000. Wetzel Investment Advisors Inc. acquired a new stake in shares of Danaher in the 4th quarter valued at $29,000. OFI Invest Asset Management acquired a new stake in shares of Danaher in the 3rd quarter valued at $30,000. Rakuten Securities Inc. acquired a new stake in shares of Danaher in the 4th quarter valued at $36,000. Finally, Financial Connections Group Inc. acquired a new stake in shares of Danaher in the 4th quarter valued at $41,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Activity

In other Danaher news, SVP Georgeann Couchara sold 2,622 shares of the business’s stock in a transaction dated Tuesday, February 13th. The shares were sold at an average price of $242.67, for a total value of $636,280.74. Following the transaction, the senior vice president now directly owns 4,244 shares in the company, valued at $1,029,891.48. The transaction was disclosed in a document filed with the SEC, which is available through this link. In other Danaher news, Director Alan G. Spoon sold 708 shares of the business’s stock in a transaction dated Thursday, May 2nd. The shares were sold at an average price of $243.58, for a total value of $172,454.64. Following the transaction, the director now directly owns 116,202 shares in the company, valued at $28,304,483.16. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, SVP Georgeann Couchara sold 2,622 shares of the business’s stock in a transaction dated Tuesday, February 13th. The shares were sold at an average price of $242.67, for a total transaction of $636,280.74. Following the completion of the transaction, the senior vice president now owns 4,244 shares in the company, valued at $1,029,891.48. The disclosure for this sale can be found here. In the last three months, insiders have sold 103,984 shares of company stock worth $25,997,094. Corporate insiders own 11.10% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on DHR shares. StockNews.com lowered shares of Danaher from a “buy” rating to a “hold” rating in a research note on Wednesday, January 31st. Bank of America lifted their target price on shares of Danaher from $258.00 to $270.00 and gave the stock a “neutral” rating in a report on Wednesday, April 24th. TD Cowen lifted their target price on shares of Danaher from $280.00 to $290.00 and gave the stock a “buy” rating in a report on Wednesday, April 24th. KeyCorp lifted their target price on shares of Danaher from $260.00 to $290.00 and gave the stock an “overweight” rating in a report on Thursday, February 1st. Finally, Barclays lifted their target price on shares of Danaher from $260.00 to $270.00 and gave the stock an “equal weight” rating in a report on Wednesday, April 24th. Six equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $267.31.

Danaher Price Performance

Shares of Danaher stock opened at $253.38 on Friday. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.51 and a current ratio of 1.85. The firm’s 50-day simple moving average is $248.07 and its 200-day simple moving average is $233.77. Danaher Co. has a twelve month low of $182.09 and a twelve month high of $259.00. The firm has a market cap of $187.68 billion, a P/E ratio of 42.95, a price-to-earnings-growth ratio of 3.90 and a beta of 0.83.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, April 23rd. The conglomerate reported $1.92 earnings per share for the quarter, beating the consensus estimate of $1.72 by $0.20. Danaher had a net margin of 16.78% and a return on equity of 11.43%. The business had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.62 billion. During the same period in the previous year, the business earned $2.36 EPS. The firm’s revenue was down 2.6% on a year-over-year basis. As a group, research analysts expect that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be given a dividend of $0.27 per share. The ex-dividend date is Friday, June 28th. This represents a $1.08 annualized dividend and a dividend yield of 0.43%. Danaher’s dividend payout ratio (DPR) is currently 18.31%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.